AMRN said the FDA accepted a new drug for review, while OII updated its financial guidance
Checking out a few of today's hot stocks on the move, we've got signs of regulatory progress for Amarin Corporation's (AMRN) experimental triglyceride drug, as well as an updated financial forecast from Oceaneering International (OII). AmarinAmarin Corporation (AMRN - 6.67) announced this morning that the Food and Drug Administration (FDA) has accepted for review an application for AMR101, the company's experimental triglyceride treatment...( Read More )
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here